Purification method of insulin detemir

A technology of insulin detemir and purification method, which is applied in the field of purification of insulin detemir, can solve the problems of reversed-phase preparation column damage, low recovery rate, environmental protection, etc., and achieve large sample loading, convenient operation and cost saving Effect

Active Publication Date: 2013-06-12
SINOPEP ALLSINO BIOPHARMACEUTICAL CO LTD
View PDF7 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Yili Lili Company (Chinese patent CN95196266.3) discloses a purification method using C4 reverse-phase high-efficiency chromatographic column; The purification method of reversed-phase chromatographic column; from the existing literature, it can be seen that the product can be obtained through the purification of reversed-phase high-performance liquid chromatography, but this purification method has high requirements for equipment, and a complete set of chromatography that can withstand high pressure is required System, and a large amount of organic reagents such as acetonitrile will be used in the preparation process, which is costly and not environmentally friendly; the adsorption of the sample on the reversed-phase preparative column is strong, resulting in low recovery rate, and it is easy to cause irreversible damage to the reversed-phase preparative column damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purification method of insulin detemir
  • Purification method of insulin detemir
  • Purification method of insulin detemir

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Embodiment 1, a method for purifying insulin detemir, the raw material is the insulin detemir solution prepared by one-step reaction of recombinant human insulin without B30 and tetradecyl fatty acid-N-succinimide ester; purification Adopt ion-exchange chromatography method to carry out, and its step is as follows:

[0029] (1) Equilibrate the cation exchange column 4.5CV with an acidic buffer solution with a sodium chloride concentration lower than 50mM and a pH value of 2; and adjust the insulin detemir solution to a pH value < 5 with the aforementioned acidic buffer solution or dilute acid of the same system , to obtain the sample solution;

[0030] (2) Put the sample solution on the cation exchange column. At this time, the tetradecyl fatty acid-N-succinimide ester will flow out without hanging on the column, and then wash the cation exchange column with equilibration buffer for 2.5CV;

[0031] (3) The various substances adsorbed on the column were eluted sequentia...

Embodiment 2

[0032] Embodiment 2, a method for purifying insulin detemir, the raw material is the insulin detemir solution prepared by one-step reaction of recombinant human insulin without B30 and tetradecyl fatty acid-N-succinimide ester; purification Adopt ion-exchange chromatography method to carry out, and its step is as follows:

[0033] (1) Equilibrate the cation exchange column at 5.5CV with an acidic buffer solution with a sodium chloride concentration lower than 50mM and a pH value of 4; and adjust the insulin detemir solution to a pH value < 5 with the aforementioned acidic buffer solution or dilute acid of the same system , to obtain the sample solution;

[0034] (2) Put the sample solution on the cation exchange column. At this time, the tetradecyl fatty acid-N-succinimide ester will flow out without hanging on the column, and then wash the cation exchange column with equilibration buffer for 3.5CV;

[0035] (3) The various substances adsorbed on the column were eluted sequen...

Embodiment 3

[0036] Embodiment 3, a purification method of insulin detemir, the raw material is the insulin detemir solution prepared by one-step reaction of recombinant human insulin de-B30 and tetradecyl fatty acid-N-succinimide ester; purification Adopt ion-exchange chromatography method to carry out, and its step is as follows:

[0037](1) Equilibrate the cation exchange column 5CV with an acid buffer solution with a sodium chloride concentration of 10 mM and a pH value of 3; and adjust the insulin detemir solution to a pH value <5 with the aforementioned acid buffer solution or dilute acid of the same system to obtain sample solution;

[0038] (2) Put the sample solution on the cation exchange column. At this time, the tetradecyl fatty acid-N-succinimide ester will flow out without hanging on the column, and then wash the cation exchange column with equilibration buffer for 3CV;

[0039] (3) The various substances adsorbed on the column were eluted sequentially by linear gradient elu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a purification method of insulin determir. The purification method comprises the following steps of: during purification, balancing a cation exchange column by an acidic buffer solution; adjusting the pH value of an insulin determir solution to be less than 5 by the acidic buffer solution or an identically systematic diluted acid, thus obtaining a sample solution; adding the sample solution on the cation exchange column, then washing the cation exchange column by a balanced buffer solution; and successively washing various adsorbed substances down from the column by a 0.5-1.0M acidic buffer solution with a pH value of 2-4 in a liner gradient elution way, and then collecting a main peak, thus obtaining a target product, namely the insulin determir. The purification method not only has the advantages of being convenient to operate, large loading quantity of samples, high recycling efficiency and the like, but also avoids the rigorous requirements that a large quantity of organic reagents and a high pressure chromatographic system are needed in a traditional purification method, so that the purification method is cost-saving, economical and environmentally-friendly, and suitable for industrial production.

Description

technical field [0001] The invention relates to a method for purifying insulin detemir, belonging to the fields of biochemistry and medicinal chemistry. Background technique [0002] Diabetes is a major disease that threatens human health worldwide. In China, with the change of people's lifestyle and the acceleration of the aging process, the prevalence of diabetes is rising rapidly. In 2010, the total number of diabetic patients in China has exceeded 90 million. Acute and chronic complications of diabetes, especially chronic complications that accumulate in multiple organs, cause disability and high mortality, seriously affect the physical and mental health of patients, and bring heavy burdens to individuals, families and society. [0003] All patients with type 1 diabetes must receive insulin therapy, and most patients with type 2 diabetes will eventually need to use insulin to control blood sugar as the disease progresses. Existing evidence shows that once diabetic pat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/62C07K1/18
Inventor 李蕴波杜家富司建萍褚杨杰孙美禄
Owner SINOPEP ALLSINO BIOPHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products